Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Pandemic strategising for cancer hospital stockpiles

Prof Richard Sullivan and Dr Aasim Yusuf
Pandemic strategising for cancer hospital stockpiles ( Prof Richard Sullivan and Dr Aasim Yusuf )
17 Feb 2022

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Feb 2022

Cancer care in Turkey: Paediatric oncology during COVID-19 and palliative care

Prof Richard Sullivan and Prof Tezer Kutluk
Cancer care in Turkey: Paediatric oncology during COVID-19 and palliative care ( Prof Richard Sullivan and Prof Tezer Kutluk )
11 Feb 2022

Eye metastasis in breast cancer: Case report and review of literature

Dr Ereny Samwel Poles Saad - Assiut University, Asyut, Egypt
Eye metastasis in breast cancer: Case report and review of literature ( Dr Ereny Samwel Poles Saad - Assiut University, Asyut, Egypt )
10 Feb 2022

Update on the new EUSOMA quality indicators for breast cancer

Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal
Update on the new EUSOMA quality indicators for breast cancer ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )
3 Feb 2022

The optimal approach after neoadjuvant treatment: The Lucerne toolbox

Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal
The optimal approach after neoadjuvant treatment: The Lucerne toolbox ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )
3 Feb 2022

Lung cancer in India

Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India
Lung cancer in India ( Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India )
3 Feb 2022

The global impact of the FDA's changing approval standards

Dr Bishal Gyawali - Queen's University, Kingston, Canada
The global impact of the FDA's changing approval standards ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
2 Feb 2022

Tumour agnostic treatments in GI cancer

Dr Nicola Normanno and Dr Katja Schmitz
Tumour agnostic treatments in GI cancer ( Dr Nicola Normanno and Dr Katja Schmitz )
1 Feb 2022

ecancer-AORTIC special issue on cancer research training in Africa

Dr Solomon Rotimi - Covenant University, Ota, Nigeria
ecancer-AORTIC special issue on cancer research training in Africa ( Dr Solomon Rotimi - Covenant University, Ota, Nigeria )
27 Jan 2022

Neoadjuvant pembro + chemo vs placebo + chemo, followed by adjuvant pembro vs placebo for early-stage TNBC

Prof Peter Schmid - Queen Mary University of London, London, United Kingdom
Neoadjuvant pembro + chemo vs placebo + chemo, followed by adjuvant pembro vs placebo for early-stage TNBC ( Prof Peter Schmid - Queen Mary University of London, London, United Kingdom )
27 Jan 2022

Durvalumab plus chemotherapy significantly improved OS in advanced biliary tract cancer

Dr Do-Youn Oh - Seoul National University College of Medicine, Seoul, South Korea
Durvalumab plus chemotherapy significantly improved OS in advanced biliary tract cancer ( Dr Do-Youn Oh - Seoul National University College of Medicine, Seoul, South Korea )
27 Jan 2022